Literature DB >> 12079292

Delivery outcomes following loop electrosurgical excision procedure for microinvasive (FIGO stage IA1) cervical cancer.

Evangelos Paraskevaidis1, George Koliopoulos, Evangelos Lolis, Eri Papanikou, Vasiliki Malamou-Mitsi, Niki J Agnantis.   

Abstract

OBJECTIVE: The goal of this study was to report the delivery outcomes in women who had loop electrosurgical excision procedure (LEEP) for microinvasive cervical cancer (stage IA1 without lymphovascular invasion) and became pregnant and progressed beyond 24 weeks.
METHODS: A case-control study was performed. Twenty-eight women who were managed exclusively with LEEP for microinvasive cervical carcinoma had at least one pregnancy beyond 24 weeks and were the cases. Each case was matched with one woman who delivered at the same department without prior treatment of her cervix (controls) and their delivery outcomes were compared with those of the cases. Known risk factors for preterm delivery were used as matching factors.
RESULTS: There was no statistically significant difference (P > 0.05) between cases and controls in the duration of pregnancy (37.6-38.4 weeks respectively), birth weight (3212-3315 g), cesarean section rate (17.8-32.1%), neonatal unit admission rate (21.4-10.7%), and precipitate labor rate (13-10.5%). The duration of labor was significantly shorter in cases (5.5-7.1 h, P = 0.032). After LEEP the relative risk for preterm delivery is 3.67 (95% confidence interval, 0.97-20.27), for low birth weight infant 0.67 (0.06-5.8), for precipitate labor 1 (0.05-3.88), and for delivery by cesarean section 0.5 (0.17-4.46).
CONCLUSIONS: Women treated for microinvasive cancer with LEEP did not have significantly more delivery complications compared with controls apart from shorter duration of labor. There was a possible non-statistically significant trend toward shorter duration of pregnancy in cases. While caution should be advised when selecting and treating women with microinvasive carcinoma by LEEP, the apparent safety of the management and the satisfactory delivery outcome seem to justify this approach in many cases. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Year:  2002        PMID: 12079292     DOI: 10.1006/gyno.2002.6650

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  Prospective Comparison of Loop Excision under Colposcopic Guidance versus Vitom Guidance.

Authors:  G F Vercellino; V Chiantera; J Gaßmann; E Erdemoglu; I Drechsler; S Frangini; A Schneider; G Böhmer
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-10-23       Impact factor: 2.915

2.  Risk of cesarean delivery after loop electrosurgical excision procedure.

Authors:  Heather A Frey; Molly J Stout; Anthony O Odibo; David M Stamilio; Alison G Cahill; Kimberly A Roehl; George A Macones
Journal:  Obstet Gynecol       Date:  2013-01       Impact factor: 7.661

Review 3.  Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis.

Authors:  M Arbyn; M Kyrgiou; C Simoens; A O Raifu; G Koliopoulos; P Martin-Hirsch; W Prendiville; E Paraskevaidis
Journal:  BMJ       Date:  2008-09-18

4.  Pregnancy Outcomes after Treatment for Cervical Cancer Precursor Lesions: An Observational Study.

Authors:  Sheila Weinmann; Allison Naleway; Geeta Swamy; Girishanthy Krishnarajah; Bhakti Arondekar; Jovelle Fernandez; Evan Myers
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

Review 5.  Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia.

Authors:  Maria Kyrgiou; Anita Mitra; Marc Arbyn; Maria Paraskevaidi; Antonios Athanasiou; Pierre P L Martin-Hirsch; Phillip Bennett; Evangelos Paraskevaidis
Journal:  Cochrane Database Syst Rev       Date:  2015-09-29

Review 6.  Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis.

Authors:  Maria Kyrgiou; Antonios Athanasiou; Maria Paraskevaidi; Anita Mitra; Ilkka Kalliala; Pierre Martin-Hirsch; Marc Arbyn; Phillip Bennett; Evangelos Paraskevaidis
Journal:  BMJ       Date:  2016-07-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.